Download Click here

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts

Disease wikipedia , lookup

Women's health in India wikipedia , lookup

Epidemiology wikipedia , lookup

Women's medicine in antiquity wikipedia , lookup

Epidemiology of metabolic syndrome wikipedia , lookup

Seven Countries Study wikipedia , lookup

Multiple sclerosis research wikipedia , lookup

List of medical mnemonics wikipedia , lookup

Fetal origins hypothesis wikipedia , lookup

Transcript
Women and Heart Disease
Saturday, June 11, 2011 Embassy Suites Nashville/South Cool Springs Dr. Patti Vanhook, Activity Director This program has been approved for 7.5 AMA PRA Category 1 CreditsTM**
and 7.33 Continuing Nursing Education Contact Hours.***
Pre Conference Activities
7:00 – 7:30 AM CDT (8:00 ‐ 8:30 AM EDT) 7:30 – 7:45 AM CDT (8:30 – 8:45 AM EDT) Breakfast Welcome and Introductions Dr. Patti Vanhook Associate Dean for Practice and Community Partnership College of Nursing East Tennessee State University Johnson City, TN Cardiovascular Disease and Women: The State of the Problem Schedule 7:45 – 8:40 AM CDT (8:45 – 9:40 AM EDT) 8:40 – 9:40 AM CDT (9:40 – 10:40 AM EDT) Topic Keynote Address: The Feminine Face of Heart Disease: What Do We Know About Angina in Women? Nanette K. Wenger, MD, MACC, MACP, FAHA Professor of Medicine (Cardiology) Emory University School of Medicine, Consultant, Emory Heart and Vascular Center Atlanta, GA The Patients’ Perspective: WomenHeart Panel Sharonne N. Hayes, MD, FACC (Moderator) Consultant in Cardiovascular Diseases Associate Professor of Medicine •
•
Learning Objectives: Describe the gender differences in clinical presentations and pathology of angina Cite the adverse outcomes of stable ischemic heart disease in women vs men 9:40 – 10:00 AM CDT (10:40 – 11:00 AM EDT) 10:00 – 10:55 AM CDT (11:00 – 11:55 AM EDT) College of Medicine Director of the Office of Diversity and Inclusion Mayo Clinic Rochester, MN Panel Members • Constance Adcock • Cyndi Brown • Brenda Taylor Break Challenges in the Diagnosis and Treatment of Coronary Heart Disease in Women Gayathri Baljepally, MD Cardiology University Cardiology Knoxville, TN •
•
•
•
Describe stable angina in women Describe gender specific diagnostic testing for cardiovascular disease Cite outcomes that will be different based on gender and their implications Describe treatment variations and bias that are gender specific Cardiovascular Disease Risk in Women 10:55 – 11:50 AM CDT (11:55 AM – 12:50 PM EDT) 11:50 AM – 12:50 PM CDT (12:50 – 1:50 PM EDT) 12:50 – 1:40 PM CDT (1:50 – 2:40 PM EDT) What Do the 2011 Guidelines Tell Us about the Prevention of Cardiovascular Disease in Women? Nanette K. Wenger, MD, MACC, MACP, FAHA •
Lunch Broken‐Hearted Women: The Relationship Between Mental •
•
Describe the 2011 AHA recommendations for Cardiovascular Disease prevention in women Cite the currently recommended categorization of cardiovascular risk for women Discuss the relationship between depression and Health and Cardiovascular Disease Sharonne N. Hayes, MD, FACC •
•
•
cardiovascular disease.
Describe sex differences in depression and anxiety.
Identify appropriate screening and diagnostic tools for depression in women with heart disease.
Describe several appropriate treatment options for depression and anxiety in women with heart disease. Strategies to Manage Women’s CVD Risk in the Primary Care Practice
1:40 – 2:10 PM CDT (2:40 – 3:10 PM EDT) 2:10 – 2:40 PM CDT (3:10 – 3:40 PM EDT) Managing Risk: Impact of Preeclampsia and Gestational Diabetes on Midlife Heart Disease Risk Elizabeth Ofili, MD, MPH, FACC Associate Dean of Clinical Research Professor of Medicine Chief of Cardiology Director, Clinical Research Center Co‐PI, Atlanta Clinical and Translational Science Institute Morehouse School of Medicine Atlanta, Georgia
Managing Risk: Effective Strategies for Managing Obesity in the Primary Care Practice: Outcomes from the Louisiana Obese Subjects Study (LOSS) Donna H. Ryan, MD, FACP Associate Executive Director for Clinical Research and Professor Pennington Biomedical Research Center Baton Rouge, LA •
•
•
•
•
•
Describe the midlife risk of CVD to women who have experienced preeclampsia and/or gestational diabetes during pregnancy Cite the epidemiologic prevalence of these complications Describe appropriate midlife primary care surveillance that is recommended for these women at risk Describe the rates of extreme obesity in the United States and in Tennessee Describe the concomitant impact on the risk for type 2 diabetes and other diseases Relate how to obtain training in application of office‐based approaches to implementing weight loss in patients with extreme •
2:40 – 3:00 PM CDT (3:40 – 4:00 PM EDT) 3:00 – 3:30 PM CDT (4:00 – 4:30 PM EDT) 3:30 – 4:00 PM CDT (4:30 – 5:00 PM EDT) Break Managing Risk: Culturally Appropriate Storytelling to Improve Blood Pressure…. Lessons Learned from a Successful Program for African Americans in Alabama Sandral Hullet, MD Family Medicine CEO and Medical Director of Jefferson Health System/Cooper Green Hospital Birmingham, Alabama Breast Cancer and Heart Disease: Winning the Battle Without Losing the War Tracy A. Johnson DNP, FNP‐BC Clinical Coordinator, Adult Survivors of Adult and Pediatric Cancers REACH for Survivorship Program Vanderbilt Ingram Cancer Center Nashville, TN •
•
•
•
•
obesity, including combinations of Low Calorie Liquid Diets, portion‐controlled diet approaches, office‐based lifestyle counseling programs, medications for obesity and appropriate referral for obesity surgery Describe the reasons for appropriate medication management of diabetes during weight loss attempts Describe the differential change in blood pressure for hypertensive African American patients with the use of storytelling DVDs Identify how lessons learned can be applied to other populations Identify cancer treatment regimens that present potential cardiac risks. Perform accurate, targeted questioning of patient's medical history to screen for cancer treatment with cardiac risks. Incorporate appropriate diagnostic testing and screenings based on cardiac risks and potential cardiac problems related to cancer treatment. •
4:00 ‐ 4:30 PM CDT (5:00 ‐ 5:30 PM EDT) Getting On With Life: Cardiac Rehabilitation and Women Theresa M. Beckie, PhD, FAHA Professor University of South Florida Tampa, Florida •
•
•
4:30 – 4:45 PM CDT (5:30 – 5:45 PM EDT) Wrap Up and Evaluation Identify potential cardiac‐
related "red flags" in clinical presentation and symptoms of cancer survivors. Describe the benefits of cardiac rehabilitation to women after a cardiac event. Cite the gender differences in referral patterns for women. Describe the potential changes in cardiac rehabilitation programs that would assure women's needs are better met. Activity Director: Dr. Patti Vanhook, Associate Dean for Practice and Community Partnership, College of Nursing, East Tennessee State University, Johnson City, TN Learning Objectives: •
•
•
•
•
•
•
•
•
Describe the epidemiological and symptomatic variations in women with coronary heart disease, and cite the physiological basis for these gender variations Describe gender specific diagnostic testing for coronary heart disease and the potential gender specific outcomes Explain the impact of stress and depression on heart disease risk in women Describe the evidence based guidelines for risk stratification in heart disease in women, and list risk management strategies for each stratification level Describe the long term impact of breast cancer treatment on women and their risk of heart disease, and list the red flag issues that may present in the primary care practice Examine the methods for supporting women in their return to active life after a cardiac event Examine strategies employed in successful programs in managing CVD risk in African Americans with hypertension Describe strategies that have been found to be effective in non surgical management of severe obesity in the primary care practice Describe the midlife CVD risk to women who have experienced pregnancy complications of Pre‐
eclampsia and Gestational Diabetes Target Audience: Family and Internal Medicine Physicians, OB/GYN Physicians, APNs and PAs. Also: Hospitalists; Emergency Physicians, Nurses and Clinical Team; Cardiologists, Cardiology Nurses and Clinical Team; Cardiac Rehabilitation Nurses and Staff, Hospital Cardiology Administrative Leadership Registration There are no fees for this activity. However, advance registration is required. You may register by calling 423‐439‐
8027, or by going online at: www.etsu.edu/cme Book Early: This is Country Music Awards weekend in Nashville, so the hotel will fill quickly. To make reservations, contact Embassy Suites Nashville South/Cool Springs by calling 615‐515‐5151, or go online to www.nashvillesouth.embassysuites.com Sponsorship: This project is funded under an agreement with the Tennessee Department of Health. The conference has been organized by the Tennessee Hospital Association and Quillen College of Medicine at East Tennessee State University. Funding for the Keynote Speaker: The funding for Dr Wenger has been underwritten by the Tennessee Chapter of the American College of Cardiologists. **The Quillen College of Medicine, East Tennessee State University, is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The Quillen College of Medicine, East Tennessee State University designates this live activity for a maximum of 7.5 AMA PRA Category 1 CreditsTM. Physicians should only claim credit commensurate with the extent of their participation in the activity. Joint Sponsorship: This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of Quillen College of Medicine at East Tennessee State University and the Tennessee Hospital Association. Quillen College of Medicine is accredited by the ACCME to provide continuing medical education for physicians. Nursing Credit: ***East Tennessee State University College of Nursing is an approved provider of continuing nursing education by the Tennessee Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation. AAFP Prescribed Credits: This Live activity, Women and Heart Disease, with a beginning date of June 11, 2011, has been reviewed and is acceptable for up to 7.00 Prescribed credits by the American Academy of Family Physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity. The program number is #51630